Brendan R. Winslow insider trades

Open-market stock purchases and sales by Brendan R. Winslow, Chief Financial Officer at Atrium Therapeutics, Inc, from SEC Form 4 filings since Apr 20, 2026.

Recent trades

DateStockTradeValue
Sep 18, 2026RNA Atrium Therapeutics, IncSold (not open market)$60.3K
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—
Apr 20, 2026RNA Atrium Therapeutics, IncBought (not open market)—

Companies traded

  • RNA Atrium Therapeutics, Inc: other filings, last Sep 18, 2026

Get free alerts when Brendan R. Winslow files a new trade →